High-flow nasal oxygen as first-line therapy for COVID-19-associated hypoxemic respiratory failure: a single-centre historical cohort study

PURPOSE: The optimal noninvasive modality for oxygenation support in COVID-19-associated hypoxemic respiratory failure and its association with healthcare worker infection remain uncertain. We report here our experience using high-flow nasal oxygen (HFNO) as the primary support mode for patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Blair Carl, Jayaraman, Dev, Yang, Stephen Su, Wong, Evan G., Lipes, Jed, Dial, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Reports of Original Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870079/
https://www.ncbi.nlm.nih.gov/pubmed/35211876
http://dx.doi.org/10.1007/s12630-022-02218-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870079/
https://www.ncbi.nlm.nih.gov/pubmed/35211876
http://dx.doi.org/10.1007/s12630-022-02218-z

Ejemplares similares